We shown that, in contrast to classical opioid receptors, ACKR3 won't cause classical G protein signaling and is not modulated via the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. In its place, we proven that LIH383, an ACKR3-selective subnanomolar https://vanh157nnj8.wikifrontier.com/user